86 related articles for article (PubMed ID: 26805324)
21. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
[TBL] [Abstract][Full Text] [Related]
22. Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients.
Uncu D; Aksoy S; Çetin B; Yetişyiğit T; Özdemir N; Berk V; Dane F; Inal A; Harputluoğlu H; Budakoğlu B; Koca D; Sevinç A; Cihan S; Durnalı AG; Özkan M; Öztürk MA; Işıkdoğan A; Büyükberber S; Benekli M; Köş T; Alkış N; Karaca H; Turhal NS; Zengin N;
Oncology; 2013; 84(4):240-5. PubMed ID: 23392240
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
24. Oral fluoropyrimidines may not reduce the risk of postoperative recurrence in colorectal cancer associated with mesenteric lymph node metastasis.
Ogata Y; Torigoe S; Matono K; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Mizobe T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
Int Surg; 2007; 92(6):314-9. PubMed ID: 18402123
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic strategy for perforated colorectal cancer].
Yoshikawa T; Akashi T; Hisano M; Asakura Y; Higashino N; Arimoto A; Hosono M; Ueno N; Ienaga T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1725-7. PubMed ID: 25731309
[TBL] [Abstract][Full Text] [Related]
26. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
27. [A questionnaire survey on QOL and toxicity in colorectal cancer survivors who received adjuvant chemotherapy].
Taniguchi H; Narita Y; Komori K; Kimura K; Kinoshita T; Komori A; Uegaki S; Nomura M; Nitta S; Yamaguchi K; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K
Gan To Kagaku Ryoho; 2015 Apr; 42(4):457-61. PubMed ID: 25963692
[TBL] [Abstract][Full Text] [Related]
28. Prolonged survival of patients with metastatic colorectal cancer following first-line oxaliplatin-based chemotherapy with molecular targeting agents and curative surgery.
Shitara K; Matsuo K; Kondo C; Takahari D; Ura T; Inaba Y; Yamaura H; Sato Y; Kato M; Kanemitsu Y; Komori K; Ishiguro S; Sano T; Shimizu Y; Muro K
Oncology; 2011; 81(3-4):167-74. PubMed ID: 22057124
[TBL] [Abstract][Full Text] [Related]
29. Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.
Collura A; Lagrange A; Svrcek M; Marisa L; Buhard O; Guilloux A; Wanherdrick K; Dorard C; Taieb A; Saget A; Loh M; Soong R; Zeps N; Platell C; Mews A; Iacopetta B; De Thonel A; Seigneuric R; Marcion G; Chapusot C; Lepage C; Bouvier AM; Gaub MP; Milano G; Selves J; Senet P; Delarue P; Arzouk H; Lacoste C; Coquelle A; Bengrine-Lefèvre L; Tournigand C; Lefèvre JH; Parc Y; Biard DS; Fléjou JF; Garrido C; Duval A
Gastroenterology; 2014 Feb; 146(2):401-11.e1. PubMed ID: 24512910
[TBL] [Abstract][Full Text] [Related]
30. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW
J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565
[TBL] [Abstract][Full Text] [Related]
31. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.
Cercek A; Siegel CL; Capanu M; Reidy-Lagunes D; Saltz LB
Clin Colorectal Cancer; 2013 Sep; 12(3):163-7. PubMed ID: 23871161
[TBL] [Abstract][Full Text] [Related]
32. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
33. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
[TBL] [Abstract][Full Text] [Related]
34. [Neoadjuvant chemotherapy with capecitabine plus oxaliplatin and bevacizumab for the treatment of patients with resectable metastatic colorectal cancer].
Kemmochi T; Egawa T; Mihara K; Ito Y; Ohkubo Y; Mori T; Nagashima A; Makino H; Yamamuro W
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1629-31. PubMed ID: 24393871
[TBL] [Abstract][Full Text] [Related]
35. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
Araujo R; Gonen M; Allen P; Blumgart L; DeMatteo R; Fong Y; Kemeny N; Jarnagin W; D'Angelica M
Ann Surg Oncol; 2013 Dec; 20(13):4312-21. PubMed ID: 23897009
[TBL] [Abstract][Full Text] [Related]
36. [Results of adjuvant chemotherapy (XELOX) of advanced colorectal cancer].
Eropkin PV; Rybakov EG; Kashnikov VN; Panina MV
Vopr Onkol; 2011; 57(2):179-83. PubMed ID: 21809662
[TBL] [Abstract][Full Text] [Related]
37. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
[TBL] [Abstract][Full Text] [Related]
38. [Emergency surgery for complicated colorectal cancer. Retrospective study].
Pansini GC; Zerbinati A; Giacometti M; Feo CV; Zamboni P; Lanzara S; Liboni A
Ann Ital Chir; 2004; 75(5):555-8. PubMed ID: 15960343
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathological Outcome of Perforated Colorectal Cancer].
Udaka T; Matsumoto N; Endo I; Yamamoto S; Yoshida O; Inokawa H; Kubo M; Mizuta M
Gan To Kagaku Ryoho; 2016 Apr; 43(4):439-42. PubMed ID: 27220789
[TBL] [Abstract][Full Text] [Related]
40. Postoperative recurrence and risk factors of colorectal cancer perforation.
Asano H; Kojima K; Ogino N; Fukano H; Ohara Y; Shinozuka N
Int J Colorectal Dis; 2017 Mar; 32(3):419-424. PubMed ID: 27796497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
